The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy [CT26]
Ontology highlight
ABSTRACT: To investigate the imunoresistance programs regulated by the CX3CL1-CX3CR1 axis, we treated CT26 mouse tumor cell line with CX3CL1, CX3CL1 + IFN-γ, IFN-γ, and no treatment
ORGANISM(S): Mus musculus
PROVIDER: GSE215269 | GEO | 2023/09/01
REPOSITORIES: GEO
ACCESS DATA